Yungjin Pharm. Co., Ltd. - Product Pipeline Review - 2016

  • ID: 3821671
  • Company Profile
  • 39 pages
  • Global Markets Direct
1 of 4
Yungjin Pharm. Co., Ltd. - Product Pipeline Review - 2016

Summary

‘Yungjin Pharm. Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the Yungjin Pharm. Co., Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Yungjin Pharm. Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Yungjin Pharm. Co., Ltd.
- The report provides overview of Yungjin Pharm. Co., Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Yungjin Pharm. Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Yungjin Pharm. Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Yungjin Pharm. Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Yungjin Pharm. Co., Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Yungjin Pharm. Co., Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Figures

Yungjin Pharm. Co., Ltd. Snapshot

Yungjin Pharm. Co., Ltd. Overview

Key Information

Key Facts

Yungjin Pharm. Co., Ltd. - Research and Development Overview

Key Therapeutic Areas

Yungjin Pharm. Co., Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Yungjin Pharm. Co., Ltd. - Pipeline Products Glance

Yungjin Pharm. Co., Ltd. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Yungjin Pharm. Co., Ltd. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Yungjin Pharm. Co., Ltd. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Yungjin Pharm. Co., Ltd. - Drug Profiles

(acetaminophen + tramadol hydrochloride) SR

Product Description

Mechanism of Action

R&D Progress

YBH-1603

Product Description

Mechanism of Action

R&D Progress

YPL-001

Product Description

Mechanism of Action

R&D Progress

YNP-1707

Product Description

Mechanism of Action

R&D Progress

YOB-1604

Product Description

Mechanism of Action

R&D Progress

ceftaroline fosamil

Product Description

Mechanism of Action

R&D Progress

YLS-1501

Product Description

Mechanism of Action

R&D Progress

YRA-1909

Product Description

Mechanism of Action

R&D Progress

YSA-2021

Product Description

Mechanism of Action

R&D Progress

YAC-1912

Product Description

Mechanism of Action

R&D Progress

YMS-1716

Product Description

Mechanism of Action

R&D Progress

YPC-1811

Product Description

Mechanism of Action

R&D Progress

YPP-2022

Product Description

Mechanism of Action

R&D Progress

YTD-2020

Product Description

Mechanism of Action

R&D Progress

Yungjin Pharm. Co., Ltd. - Pipeline Analysis

Yungjin Pharm. Co., Ltd. - Pipeline Products by Target

Yungjin Pharm. Co., Ltd. - Pipeline Products by Route of Administration

Yungjin Pharm. Co., Ltd. - Pipeline Products by Molecule Type

Yungjin Pharm. Co., Ltd. - Pipeline Products by Mechanism of Action

Yungjin Pharm. Co., Ltd. - Dormant Projects

Yungjin Pharm. Co., Ltd. - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Yungjin Pharm. Co., Ltd., Key Information

Yungjin Pharm. Co., Ltd., Key Facts

Yungjin Pharm. Co., Ltd. - Pipeline by Indication, 2016

Yungjin Pharm. Co., Ltd. - Pipeline by Stage of Development, 2016

Yungjin Pharm. Co., Ltd. - Monotherapy Products in Pipeline, 2016

Yungjin Pharm. Co., Ltd. - Combination Treatment Modalities in Pipeline, 2016

Yungjin Pharm. Co., Ltd. - Pre-Registration, 2016

Yungjin Pharm. Co., Ltd. - Phase III, 2016

Yungjin Pharm. Co., Ltd. - Phase II, 2016

Yungjin Pharm. Co., Ltd. - Phase I, 2016

Yungjin Pharm. Co., Ltd. - Preclinical, 2016

Yungjin Pharm. Co., Ltd. - Discovery, 2016

Yungjin Pharm. Co., Ltd. - Pipeline by Target, 2016

Yungjin Pharm. Co., Ltd. - Pipeline by Route of Administration, 2016

Yungjin Pharm. Co., Ltd. - Pipeline by Molecule Type, 2016

Yungjin Pharm. Co., Ltd. - Pipeline Products by Mechanism of Action, 2016

Yungjin Pharm. Co., Ltd. - Dormant Developmental Projects,2016 36List of Figures

Yungjin Pharm. Co., Ltd. - Pipeline by Top 10 Indication, 2016

Yungjin Pharm. Co., Ltd. - Pipeline by Stage of Development, 2016

Yungjin Pharm. Co., Ltd. - Monotherapy Products in Pipeline, 2016

Yungjin Pharm. Co., Ltd. - Pipeline by Target, 2016

Yungjin Pharm. Co., Ltd. - Pipeline by Route of Administration, 2016

Yungjin Pharm. Co., Ltd. - Pipeline by Molecule Type, 2016

Yungjin Pharm. Co., Ltd. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll